Nanocellulose biomaterials & aerogels (CNC, CNF, BNC and cellulose aerogels)

01Overview and value chain

Markers: [EC: EU REACH + FDA/EFSA food-contact | OECD: Bio-based materials, Circular bioeconomy | Regulator: FDA (USA), EFSA (EU), REACH (EU)]

Nanocellulose biomaterials are cellulose reduced to the nanometre scale — cellulose nanocrystals (CNC), cellulose nanofibrils (CNF, also called microfibrillated cellulose), and bacterial nanocellulose (BNC) — yielding the strongest, lightest bio-based materials known, with exceptional strength-to-weight ratio, tunable barrier properties and full biodegradability. The global nanocellulose market was valued at about 392 million dollars in 2025 and is forecast to reach roughly 1.22 billion dollars by 2035, a compound annual growth rate near 12%. Stora Enso, Europe’s leading fluff-pulp producer, is investing 19 million euros to lift its Skutskar (Sweden) fluff-pulp capacity by about 10 percent to 440,000 tonnes per year; Sappi markets the Valida fibrillated-cellulose line that builds 3D water-dispersed networks for cosmetics and coatings; and CelluForce runs cellulose-nanocrystal production for packaging, biomedical and advanced-material uses. In China, Yueyang Forest Paper’s Juntaí subsidiary has built 20,000 tonnes per year of high-purity softwood lignin capacity from pulping black liquor at 100 percent utilization, while a 2026 MDPI review underlines cellulose nanomaterials’ exceptional mechanical, thermal and barrier properties. REACH, FDA and EFSA clear these materials for food-contact, cosmetic and biomedical use, and their bio-based origin earns them the ISCC PLUS and USDA BioPreferred premiums.

The key directions of nanocellulose biomaterials are:

1. Cellulose nanocrystals (CNC, CelluForce): acid-hydrolysis-derived highly crystalline whiskers with the highest stiffness of any biomaterial, used in packaging, composites and biomedical applications — the core of the CNC market forecast to triple by 2035.
2. Cellulose nanofibrils / MFC (Sappi Valida, Borregaard Exilva): mechanically fibrillated cellulose forming 3D networks that stabilize formulations, gels and barrier coatings without raising viscosity.
3. Bacterial nanocellulose (BNC): microbially synthesized pure cellulose for biomedical, acoustic-membrane and food applications, where its high purity and water-holding capacity win.
4. Cellulose aerogels and lignin co-products (Stora Enso, Yueyang): freeze-dried cellulose aerogels for insulation and oil-spill sorption, with lignin valorization (Yueyang’s 20,000 tonnes per year) spreading pulping economics across multiple biomaterial streams.

Sectoral value chain

[Wood pulp / biomass feedstock] ──> [Fractionation: cellulose + hemicellulose + lignin] ──> [Nanofibrillation / acid hydrolysis / bacterial synthesis]
                                                                                          │
                                                                              (drying, surface modification, aerogel formation)
                                                                                          │
                                                                                          ▼
[End markets: composites · packaging · coatings · biomedical · aerogels] <─── [Nanocellulose & aerogel products]

Value chain levels

Cross-cutting technologies of the sector:

• Surface modification and compatibilization: grafting and esterification tune nanocellulose for dispersion in hydrophobic polymer matrices, the key to composite performance.
• Aerogel freeze-drying: sublimation drying of nanocellulose gels yields ultra-light, porous aerogels for thermal insulation and oil-spill sorption.
• Lignin co-valorization: routing the lignin byproduct to dispersants, carbon fibers and aromatics (Yueyang’s 20,000-tonne stream) spreads the biorefinery capex across multiple revenue lines.

02US

The United States and Canada lead cellulose-nanocrystal commercialization through CelluForce’s Windsor (Quebec) plant, with FDA food-contact clearance and a deep composites-and-packaging customer base under the USDA BioPreferred programme.

Cellulose nanocrystals, composites, food-contact clearance

• CelluForce: the cellulose-nanocrystal joint venture (FPInnovations and Domtar) runs CNC production for high-performance packaging, biomedical and advanced-material applications, riding a market forecast to grow from 392 million dollars in 2025 to about 1.22 billion by 2035.
• BioPreferred and composites pull: the USDA BioPreferred programme and US automotive and packaging demand for lightweight bio-composites anchor the offtake that makes CNC economics work, with FDA clearance enabling direct food-contact uses.
• North American R&D depth: the US Forest Products Laboratory and university consortia feed CelluForce-class producers with the surface-chemistry and scale-up know-how.

03CN

China’s pulp majors are turning pulping black liquor and agricultural residues into bio-based new materials, anchored by Yueyang Forest Paper’s Juntaí subsidiary under the “15th Five-Year Plan” push on new materials.

Lignin co-valorization, bio-based new materials push

• Yueyang Forest Paper (600963): its Juntaí bio-based new-materials subsidiary uses agricultural residues and pulping black liquor to run 20,000 tonnes per year of high-purity softwood lignin at 100 percent utilization, with a 1,500-tonne 2026 order to Hunan Lvyue and plans to extend into functional materials and dispersants.
• From cellulose to high-value: the company frames the lignin stream as the first step into higher-value functional and dispersant materials, the same logic that pulls cellulose pulp toward nanocellulose and aerogels.
• Policy tailwind: the inclusion of new materials in the strategic-emerging-industries category of the 15th Five-Year Plan underwrites the build-out of China’s bio-based materials capacity.

04EU

Europe pairs the world’s largest forestry-biomaterials companies — Stora Enso and UPM — with Sappi’s fibrillated-cellulose line, under a REACH and EFSA regime that rewards renewable, low-tox materials.

Forestry giants, fibrillated cellulose, REACH pull

• Stora Enso (STERV): Europe’s leading fluff-pulp producer is investing 19 million euros to lift Skutskar (Sweden) fluff-pulp capacity by about 10 percent to 440,000 tonnes per year, strengthening the fibre base for hygiene and biomaterials.
• UPM (UPM): the BioFore group develops cellulose and nanocellulose materials across packaging, composites and labels, anchored by the exceptional mechanical and barrier properties highlighted in 2026 nanocellulose reviews.
• Sappi (SAP): the Valida fibrillated-cellulose line forms stable 3D water-dispersed networks that stabilize cosmetic and coating formulations without viscosity rise, protecting sensitive actives like UV filters.

05Leading companies and research institutes

06Tech stack and innovations

The nanocellulose stack rests on four pillars: cellulose nanocrystal hydrolysis, nanofibril mechanical processing, bacterial nanocellulose synthesis, and aerogel freeze-drying — together turning wood pulp into the strongest and lightest bio-based materials.

1. Cellulose nanocrystals (CNC):
   • Sulphuric-acid hydrolysis dissolves the amorphous regions of cellulose, leaving highly crystalline nanocrystal whiskers with the highest elastic modulus of any biomaterial, used in packaging, composites and biomedical matrices by CelluForce.
   • Acid recovery, surface charge control and drying energy are the levers that decide CNC cost and whether it can enter high-volume packaging.
2. Cellulose nanofibrils (CNF / MFC):
   • Mechanical fibrillation (grinding, microfluidization, enzymatic pre-treatment) separates pulp into nanometre-scale fibrils that form 3D networks (Sappi Valida, Borregaard Exilva), stabilizing gels, coatings and barrier films without raising viscosity.
   • Energy consumption of fibrillation is the dominant cost, making enzymatic and TEMPO-mediated pre-treatment the route to economical CNF.
3. Bacterial nanocellulose (BNC):
   • Microbes such as Komagataeibacter synthesize pure cellulose pellicles with high water-holding capacity, used in wound dressings, acoustic membranes and low-calorie foods.
   • Fermentation titre and downstream dewatering set the cost, which is why BNC stays in high-value biomedical and food niches rather than bulk materials.
4. Cellulose aerogels and lignin co-products:
   • Freeze-drying nanocellulose gels yields ultra-light porous aerogels for thermal insulation and oil-spill sorption, extending the material into construction and environmental uses.
   • Co-valorizing the lignin stream (Yueyang’s 20,000 tonnes per year) into dispersants and functional materials spreads biorefinery capex across multiple biomaterial revenue lines.

07Value chains and production pipelines

Industrial pipeline of cellulose nanofibrils (CNF) from Kraft pulp (REACH / food-contact)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Wood-pulp feedstock     │ ───> │ 2. Pre-treatment          │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Concentration & drying │ <─── │ 3. Mechanical fibrillation│
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Formulation            │ ───> │ 6. Application & clearance │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Wood-pulp feedstock

Softwood or dissolving pulp (Stora Enso’s 440,000-tonne-per-year Skutskar stream) provides the high-cellulose feedstock; pulp brightness and hemicellulose content set the nanofibril quality.

Stage 2: Pre-treatment

Enzymatic or TEMPO-mediated pre-treatment weakens the cellulose fibre structure to cut the energy needed for fibrillation, the single largest operating cost in CNF production.

Stage 3: Mechanical fibrillation

Grinding, homogenization or microfluidization separate the pre-treated fibres into nanometre-scale fibrils, forming the 3D water-dispersed network that gives Sappi Valida its stabilizing power.

Stage 4: Concentration and drying

The dilute nanofibril suspension is concentrated and, where required, spray- or freeze-dried into a merchant powder or gel, or carried forward to aerogel formation.

Stage 5: Formulation

The nanocellulose is compounded into cosmetics, coatings, composites or barrier films, with surface modification tuning its compatibility with the host matrix.

Stage 6: Application and clearance

The finished biomaterial enters packaging, personal-care, composite and biomedical products, with REACH registration and FDA/EFSA food-contact clearance completing the route to market.